Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLOFITAMAB for Mantle cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 60 adverse event reports in the FDA FAERS database where GLOFITAMAB was used for Mantle cell lymphoma.

Most Reported Side Effects for GLOFITAMAB

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 415 37.2% 102 239
Disease progression 183 16.4% 78 39
Off label use 129 11.6% 37 44
Death 125 11.2% 125 12
Neutropenia 109 9.8% 18 59
Pyrexia 78 7.0% 15 46
Febrile neutropenia 69 6.2% 2 55
Covid-19 62 5.6% 11 31
Drug ineffective 53 4.8% 10 10
Immune effector cell-associated neurotoxicity syndrome 45 4.0% 17 16
Infection 44 3.9% 28 12
Pneumonia 41 3.7% 11 20
Sepsis 29 2.6% 15 14
Septic shock 27 2.4% 20 15
Alanine aminotransferase increased 26 2.3% 2 15

Other Indications for GLOFITAMAB

Diffuse large b-cell lymphoma (535) Product used for unknown indication (107) B-cell lymphoma (95) Diffuse large b-cell lymphoma refractory (55) Non-hodgkin's lymphoma (44) Diffuse large b-cell lymphoma stage iv (38) Follicular lymphoma (29) B-cell lymphoma refractory (27) Richter's syndrome (24) Lymphoma transformation (19)

Other Drugs Used for Mantle cell lymphoma

IBRUTINIB (6,306) RITUXIMAB (3,940) LENALIDOMIDE (2,989) CYCLOPHOSPHAMIDE (1,815) DOXORUBICIN (1,396) VENETOCLAX (1,367) VINCRISTINE (1,361) BENDAMUSTINE (1,227) CYTARABINE (1,174) DEXAMETHASONE (949)

Related Pages

GLOFITAMAB Full Profile All Mantle cell lymphoma Drugs GLOFITAMAB Demographics GLOFITAMAB Timeline